GELS — Gelteq Limited Ordinary Shares

Open full analysis

Chart, dilution, float and news for GELS in the TickerWise workspace.

Gelteq Limited, established in 2017 and based in Caulfield, Australia, specializes in creating and commercializing advanced gel-based delivery methods for both human and animal use. The company offers customizable, white-label gel formulations that can be applied to a broad array of goods, such as prescribed pharmaceuticals, non-prescription remedies, nutritional supplements (including sports-related products), and veterinary care items.

Company profile

• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic
• Country: AU
• Exchange: NASDAQ Global Select
• Employees: 7
• Website: https://www.gelteq.com

Latest SEC filings for GELS

• 2026-07-066-K
• 2026-06-306-K
• 2026-06-026-K
• 2026-05-266-K
• 2026-03-246-K
• 2025-12-096-K
• 2025-11-1720-F
• 2025-11-03NT 20-F
• 2025-08-29424B3
• 2025-07-25F-1/A

Open full analysis

Educational tool only — not investment advice.